What To Know
- He also served as a member of the Board of Overseers of the Wharton School at the University of Pennsylvania and as chairman of AdvaMed, the medical technology industry association.
- Collins' and Harrington's decades of commercial and entrepreneurial experience in the medical device field provide ExplORer Surgical and its executive team a valuable resource to help direct the company’s strategy.
October 13, 2020
Art Collins, former chairman and CEO of Medtronic, has been appointed senior advisor of ExplORer Surgical and Denis Harrington, former CEO of BridgePoint Medical, has been appointed to its Board of Directors. Collins’ and Harrington’s decades of commercial and entrepreneurial experience in the medical device field provide ExplORer Surgical and its executive team a valuable resource to help direct the company’s strategy.
Art Collins has over 30 years of experience in the medtech industry, first with Abbott Laboratories and later with Medtronic where he served as chairman & CEO from 2001 to 2008. During his 15-year tenure as CEO and COO of Medtronic, revenues and earnings per share grew at a compounded growth rate of over 15 percent. He is currently a member of Boeing’s board of directors and is a past director of Alcoa, Arconic, Cargill, Tennant, and US Bancorp. He also served as a member of the Board of Overseers of the Wharton School at the University of Pennsylvania and as chairman of AdvaMed, the medical technology industry association.
“We all know that 2020 has created a new normal for hospitals and medtech companies as they increasingly embrace remote and digital technology. ExplORer was well-positioned before the pandemic, and this year has accelerated the demand for their cutting-edge platform that helps ensure best practices and streamlines workflows to better ensure procedural proficiency,” said Collins. “I believe the company is well-positioned to achieve rapid growth and I am looking forward to my association with them.”
Harrington is the owner of Denis L Harrington Consulting, LLC, a management and strategy consulting firm he established after nearly 30 years of successful leadership in the medical device industry. He previously served as CEO for BridgePoint Medical and NexGen Medical, successfully leading BridgePoint from its development stage through commercialization and successful acquisition by Boston Scientific. Currently, he serves as an executive consultant and board director for several medical device companies.
“I am excited to join ExplORer Surgical’s Board of Directors,” said Harrington. “I have spent over 30 years in the medical device business, and I am extremely impressed by ExplORer’s potential. As the healthcare ecosystem rapidly evolves and changes, platforms like ExplORer will play an increasingly critical role in delivering insight, information, and best practices to optimize outcomes and improve efficiencies in all healthcare procedure suites. ExplORer’s ability to deliver remote coaching and constantly update itself for continuous automated improvement make it an indispensable tool for med-tech sales reps to support complex procedures and deliver optimized service.”
ExplORer provides meaningful value to an organization’s functions and the surgical teams they work with, including sales, training, medical affairs, marketing, and research and development.
